










































Molecular changes in fibrillar collagen in myxomatous mitral
valve disease
Citation for published version:
Hadian, M, Corcoran, BM & Bradshaw, JP 2010, 'Molecular changes in fibrillar collagen in myxomatous
mitral valve disease' Cardiovascular Pathology, vol. 19, no. 5, pp. e141–e148. DOI:
10.1016/j.carpath.2009.05.001
Digital Object Identifier (DOI):
10.1016/j.carpath.2009.05.001
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:




Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 05. Apr. 2019
Cardiovascular Pathology 19 (2010) e141–e148Original Article
Molecular changes in fibrillar collagen in myxomatous mitral valve disease
Mojtaba Hadiana,⁎, Brendan M. Corcoranb, Jeremy P. Bradshawa
aVeterinary Biomedical Sciences, Royal (Dick) School of Veterinary Studies, University of Edinburgh, Summerhall, EH9 1QH Edinburgh, UK
bHospital for Small Animals, Veterinary Clinical Sciences, Easter Bush Veterinary Centre, Royal (Dick) School of Veterinary Studies, University of Edinburgh,
EH25 9RG Roslin Midlothian, UK
Received 4 November 2008; received in revised form 24 April 2009; accepted 19 May 2009Abstract
Introduction:Myxomatous mitral valve disease (MMVD) is the single most common acquired cardiac disease of dogs and is a disease of
significant veterinary importance. It also bears close similarities to mitral valve prolapse in humans and therefore is a disease of emerging
comparative interest. We have previously mapped the structure of collagen fibrils in valve leaflets using synchrotron X-rays and have
demonstrated changes in collagen structure associated with the regions of disease. Methods: Differential scanning calorimetry (DSC),
biochemical assay of collagen content, high-performance liquid chromatography (HPLC), and neutron diffraction were combined with
further analysis of our previous X-ray data to elucidate molecular changes in fibrillar collagen in mild to moderately affected MMVD dogs.
Results: Comparing diseases and adjacent grossly uninvolved areas in the same leaflets, there was a 20% reduction in collagen fibrils, but
only a 10% depletion of collagen content. The enthalpy of collagen denaturation was reduced in affected areas. Chromatography showed a
25% decrease in mature nonreducible covalent cross-links in the affected samples, and neutron diffraction data showed fewer reducible
immature covalent cross-links in grossly uninvolved tissue samples. Conclusions: Mild to moderate MMVD in the dog is associated with a
marginal decline in collagen content in overtly diseased areas of valves, but more importantly is associated with an increase in immature
collagen content. These changes will contribute to the mechanical dysfunction of the leaflet, and this study provides important information on
the structure–mechanical alterations associated with this disease. The data suggests MMVD involves a dyscollagenesis process in the
development of valve pathology. © 2010 Elsevier Inc. All rights reserved.Keywords: Myxomatous mitral valve (MMV); Differential scanning calorimetry (DSC); Neutron diffraction; High-performance liquid chromatography
(HPLC); Collagen; Dog1. Introduction
Myxomatous mitral valve disease (MMVD) is the single
most common acquired cardiac disease of dogs and is a
disease of significant veterinary importance. It has a close
breed and age association, such that certain breeds are
overrepresented and all middle-to old-aged dogs will have
varying degrees of disease [1,2]. It is also of comparativeThe work was supported by the Institute Laue Langevin (Grenoble,
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Spaniel Club of England. Mojtaba Hadian is sponsored by Iran Ministry of
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doi:10.1016/j.carpath.2009.05.001interest in that it bears close similarity to mitral valve
prolapse in humans [3]. This disease is of increasing
importance in the ageing human population and involves
major research activity in the areas of novel surgical
techniques and tissue engineering of prosthetic replacement
valves. The condition, in both dogs and humans, is typified
by the loss of mechanical integrity of the valve leaflets,
failure of proper coaptation of the leaflet edges during
ventricular systole, and mitral valve regurgitation. This loss
of mechanical integrity is a consequence of the destruction of
the fibrosa layer, expansion of the loose connective tissue
spongiosa layer, and excessive accumulation of glycosami-
noglycans [2,4–6]. However, there are conflicting data on
the exact role of collagen depletion or alteration in this
disease in both dogs and humans [4,6–8]. Collagen
abnormalities have been identified in affected dogs on
e142 M. Hadian et al. / Cardiovascular Pathology 19 (2010) e141–e148transmission electron microscopy, and we have previously
shown altered collagen distribution using X-ray diffraction
[9,10]. This and other data support the idea that MMVD is a
dyscollagenesis disorder and is associated with valve
interstitial cell phenotypic transformation and migration in
both dogs and humans [11–14]. The valve interstitial cells
are responsible for extracellular matrix production, and those
alterations in the ECM, including changes in collagen
organization, are presumed to contribute to the mechanical
instability of affected valves [2,9,10,13].
We are interested in investigating changes in fibrillar
collagen in MMVD. All the fibril-forming collagens,
including Types I, II, III, V, and IV, have a triple-helical
structure which contains approximately 1000 amino acids
measuring 300 nm in length. Collagen is synthesized as the
precursor procollagen containing non-triple-helical amino-
(N) and carboxylic-terminal (C) extensions. Formation of
fibrils requires an initial linear and lateral aggregation that is
promoted by the presence of these two propeptide extensions,
but also physically limited by their presence. The removal of
the N-propeptide and C-propeptide allows closer lateral
assembly. The resulting structure displays the classic micro-
scopic features of tissue collagen fibrils. Prior to maturation,
electrostatic forces, hydrogen bonds, and hydrophobic
interactions are mainly responsible for holding these mole-
cules together. However, as fibrils mature, they develop from a
highly solublematerial to an insoluble and inert structure. This
transformation is largely attributed to the formation of strong
inter- and intramolecular cross-links, and these cross-links are
vital for providing collagen matrices with stability and tensile
strength. The type and degree of cross-linking vary between
different tissues and are affected by a variety of factors,
including the degree of posttranslational modification and
molecular packing [15,16]. In the absence of cross-links, the
molecules are capable of sliding against each other resulting in
a very weak and extensible fiber, for example, as found in
some forms of osteogenesis imperfecta [17].
We have previous shown alteration in collagen distribu-
tion in canine MMVD [10], and the current study was
designed to investigate collagen content and the nature of
cross-linking, including mature and immature forms, in the
collagen fibrils of valve leaflets affected by MMVD. This
involved measurement of the thermal properties of the
collagen using differential scanning calorimetry (DSC),
quantitative assay of collagen content using a hydroxyproline
assay, and investigation of cross-links using neutron diffrac-
tion and high-performance liquid chromatography (HPLC).2. Materials and methods
2.1. Animals
Mitral valve leaflets were obtained from middle-aged
dogs (average age approximately 7 years) presented to the
Hospital for Small Animals, the University of Edinburgh foreuthanasia. All procedures and sampling were carried out
with full owner consent. Mitral valve complexes were
obtained within 10 min of death, gently washed with
phosphate-buffered saline (PBS), and immediately snap
frozen in dry ice using OTC as cryoprotectant and stored at
−60°C until required. At the time of collection, the extent of
valve pathology was assessed by two experienced veterinary
cardiologists and attributed a gross pathological grade
according to the method of Whitney [18]. Briefly, this
classification grades valve leaflet 1 to 4, with Grade 4
indicating severe pathological change. All leaflets in this
study graded between 1 and 2, indicating moderate disease,
where visibly diseased areas coexisted adjacent to areas of
grossly uninvolved valve tissue. This also gave us the
opportunity of comparing the affected areas with healthy
ones in the same valve leaflet, since the opportunity to
identify age-matched normal valves in the pet dog popula-
tion is extremely difficult. Since MMVD equally affects the
anterior (septal) and posterior (mural) leaflet in the dog, the
tissue from both leaflets was pooled for sampling [12].
Prior to each experiment, the samples were allowed to
thaw at room temperature and then were again gently cleaned
with PBS. Diseased and the adjacent grossly uninvolved
areas from different leaflets were identified and carefully
excised. Since type I collagen is the main constituent of
tendons (N95%) [19], dog and rat tail tendon were also
obtained for comparison. All reagents and chemicals were
supplied by Sigma-Aldrich unless specified otherwise.
2.2. Differential scanning calorimetry
Tissue samples were chosen and excised from the affected
and the adjacent grossly uninvolved areas of the valve
leaflets, as described above. They were blotted with a soft
tissue. After weighing the samples, calorimetric measure-
ments were performed using a Perkin-Elmer Pyris 1
differential scanning calorimeter. Heating was carried out
from 10°C to 80°C at a rate of 5°C/min, after initial holding
at 10°C for 2 min. An empty pan was used as a reference.
The onset temperature and enthalpy (ΔH) were calculated
from thermograms for each process. The enthalpy was
determined from the area between extrapolated peak onset
and extrapolated peak completion. In total, for the purpose of
the DSC experiment, 10 diseased and seven unaffected
samples (from four different leaflets obtained from dogs)
were examined. Dog and rat tail tendons were also run for
comparison and to ensure reproducibility of the data. After
completion of the measurements, the sample pans were
punctured and placed under vacuum for 3 h to desiccate
before they were reweighed. The instrument was calibrated
with indium and water as standards.
2.3. Hydroxyproline assay
An adapted form of the Bergman and Loxley method was
used to determine the hydroxyproline content of mitral
Table 1
Gradient used in HPLC









Mobile phases were NaH2PO4 40 mM adjusted to pH 7.8 with 2 M NaOH
(Buffer A) and acetonitrile/methanol/water (45:45:10) (Buffer B).
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collagen, where it comprises 13.4% of the protein, the total
concentration of collagen can be determined by multiplying
the hydroxyproline value by 7.46. Mitral valve leaflets (three
diseased and three healthy from different dogs) were selected
and cut to produce 3×3-mm samples, and their wet weight
measured. Additional samples were prepared from dog tail
tendon. The tissues were dehydrated in 1 ml acetone
(60 min) and degreased in 2 ml petroleum ether (120 min).
The fragments were dried in an incubator at 100°C for
30 min. Drying continued in a freeze-dryer for 6 h. The
samples were reweighted again (dry weight). One hundred
microliters of 6N HCl was added to each test tube and they
were sealed under vacuum. The sealed tubes were incubated
at 110°C for 12 h. The hydrolysates were then dried,
resuspended in 1 ml HCl (1 mM), and transferred into 1.5-ml
Eppendorf tubes. They were centrifuged at 10,000 rpm for
15 min. The supernatants were used for the next step of the
experiment. This preparation was carried out in triplicate for
each sample. To 100 μl of supernatant in each test tube, the
following reagents were added in order: 400 μl HCl (1 mM);
1 ml isopropanol; and 500 μl of an oxidant solution. The
antioxidant solution contained 1 ml of 7% chloramine T
made in distilled water added to 4 ml of acetate/citrate buffer,
pH 6 (14.3 mg sodium acetate trihydrate, 9.4 g trisodium
citrate dihydrate, and 1.4 g citric acid monohydrate were
dissolved in 96 ml isopropanol and made up to 250 ml with
distilled water). Standard hydroxyproline solutions of 1.5, 1,
1/2, 1/4, 1/8, 1/16, 1/32, 1/64, and 1/128 mg/ml were made
from L-4-hydroxyproline (Fluka Biochemika) and treated in
the same way. A blank control was made by adding 500 μl
1 mM HCl instead of the supernatant or standard solution.
The tubes were vortexed and left at room temperature for
4 min. Five hundred microliters of freshly prepared Ehrlish's
reagent solution, containing 3 ml of Ehrlish's reagent (10 g
paradimethylaminobenzaldehyde in 11 ml 70% perchloric
acid) mixed with 16 ml isopropanol, was added to all tubes.
The tubes were vortexed again and incubated in a water bath
at 37°C for 2 h. The absorbance was read at 550 nm (Varian
Cary 50 Scan spectrophotometer) for all the samples, and the
concentration of hydroxyproline was calculated against the
standard graph.
2.4. Neutron diffraction
The ability of sodium borohydride (NaBH4) to react and
reduce the keto-amine and Schiff base groups of mostly
aldehyde-based cross-links has been reported previously
[15]. The introduction of deuterons into an ordered
structure will alter the neutron scattering density profile
and therefore its diffraction pattern. Sodium borodeuteride
(NaB2H4, 98 atom % D) was used to target the reducible
cross-links specifically, using the method of Wess et al.
[21].The reducing solution was made by dissolving 70 mg
of sodium borodeuteride to 5 ml PBS at pH 7.5. Each
fresh sample (approx. 1 g in weight) was immersedseparately for 20 min followed by washing with PBS at
pH 7.4 to stop the reaction.
The instrument D22 at the Institut Laue-Langevin
(Grenoble, France) was used to collect small angle scattering
data with 7 Å wavelength neutrons. The 96×96-cm detector
was placed at two positions, 2.5 and 11.2 m, to collect data
spanning the range from the first to the seventh order of
meridional diffraction. Neutron scattering data were collected
from each mitral valve leaflet sample at each detector
position, and then the same samples were treated with sodium
borodeuteride and remeasured. Due to constraints on the
allocated instrument time, it was only possible to run three
samples (one affected and one diseased mitral valve from
different dogs and one dog tail tendon from another dog). An
empty cell and detector-calibration (water cell) measure-
ments were also performed, for use in correcting and
analyzing the data. The LAMP program (Large Array
Manipulation Program, Institut Laue-Langevin) was used to
normalize the data towater with all corrections (transmissions
and background) carried out on radially averaged data.
Diffraction spectra were obtained by sector summation, and
ratios of diffracted intensity were calculated for each of the
seven orders of meridional diffraction by dividing the
diffracted intensity of treated tissue by the corresponding
intensity of untreated tissue. The data sets have been scaled to
give a first-order ratio of 1.0. For comparison, equivalent data
from an earlier study of rat tail tendon, by Wess et al. [22],
were analyzed in the same manner.
2.5. High-performance liquid chromatography
Acetonitrile (HPLC gradient grade), methanol (chroma-
solve), sodium dihydrogen orthophosphate (NaH2PO4),
boric acid, and o-phthalaldehyde (OPA-complete solution)
were used in this experiment and purchased from Sigma-
Aldrich. The mature standard cross-links, pyridinoline
(PYD), and deoxypyridinoline (DPD) were kindly supplied
by the Rowett Research Institute (Aberdeen, UK). Standard
single amino acid collection was from VWR. Chromato-
graphy condition was mostly in accordance with the
Bartolomeo and Maisano [23] methods. Chromatography
was performed on a Pharmacia LKB.VWM 2141 HPLC
system at room temperature using Phenomenex Luna 5 μm
Table 2
Comparison of thermal parameters for collagen denaturation in dog tail
tendon, healthy (grossly uninvolved) dog mitral valve leaflets, and valve
leaflets from dogs affected by MMVD
Onset temperature Peak temperature Enthalpy (ΔH)
Dog tail 64.56°C±0.23 65.75°C 8.52 J/g±0.19
Healthy leaflets 65.10°C±0.35 66.37°C 1.75 J/g±0.07
Affected leaflets 64.60°C±0.30 65.45°C 1.40 J/g±0.05
Data are shown as mean values. Measurements were performed on a
Perkin-Elmer Pyris 1 differential scanning calorimeter.
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detection at λ=338 nm. Mobile phases were NaH2PO4 40
mM adjusted to pH 7.8 with 2 M NaOH (Buffer A) and
acetonitrile/methanol/water (45:45:10) (Buffer B). Table 1
shows the gradient that was followed for the runs at 2 ml/min.
2.5.1. Precolumn derivatization
The reaction of OPA with primary amines is the result of
the formation of an OPA2/2-mercaptoethanol adduct which
then reacts with the primary amine of the amino acid to form
a highly fluorescent and UV absorbent thio-substitute
isoindoles. However, some amino acids cannot be detected
by OPA. Proline possesses a secondary amine group and is
unable to react with OPA, and the reaction with cysteine also
leads to a low response [24]. The reaction is rapid and
proceeds at room temperature.
To establish the least sufficient and appropriate concen-
tration ratio of OPA with the given sample in terms of
standard amino acids and standard mature cross-links, a total
of approximately 100 runs of HPLC were performed. The
following approach proved to work best under our laboratory
conditions. Regarding the detection of a single primary
amino acid, mixing 7.5 nM of OPA with 1 nM of a given
amino acid in 0.4 M borate (pH=10.4) and 0.1 M sodium
acetate (pH=7.2) and incubation for 1 min at room
temperature before injection produced the best results.
A series of runs demonstrated that, at the ratio of 37.5 nM
of OPA to 1 nM of DPD or PYD, there was an optimum
reaction (Fig. 1). The increased amount of OPA might be
explained by the fact that the molecules of the cross-links
contain three primary amine groups. Nonetheless, this
increase is not proportional when it is compared with the
molar concentration of OPA used for determining standard
profile single amino acids.
2.5.2. Collagen extraction
Rat tail was frozen immediately after removal from donor
rats. During processing, samples were placed in a Petri dish
containing 70% ethanol for 20 min. The tip of the tail was cut
crosswise with scissors. The skin was pulled back 1/4 in. to
expose the tendons, and then each tendon was pulled out with
blunt tip forceps. After that, the samples were washed with
PBS buffer and cut into pieces (approx. 5×5 mm). Freshly
frozen mitral valves were let thaw at room temperature, and
then the same procedure was repeated with the onlyFig. 1. A typical chromatogram of mature standard cross-links at 1 nM
concentration each: pyridinoline (A) and deoxypyridinoline (B).difference that, after cutting them into pieces, they were
homogenized. In total, four diseased and four healthy
collagen samples were obtained from two diseased and two
healthy valve leaflets (Grade 1–2). Collagen was isolated
from the rat tail tendons and mitral leaflet samples using
previously described methods [25] by dissolving in 0.017 M
acetic acid at 4 g/l. The solution was mildly agitated by
stirring for 48 h at 4°C. In order to purify the collagen
solution, the samples were centrifuged at high speed
(10,000×g) at 4°C for 1 h in a fixed-angle rotor (JA-20;
Beckman Coulter) using a Beckman Coulter high-speed
centrifuge [26]. Supernatants were separated and dried using
a lyophilizer at −40°C for 12 h. They were weighed into 5-mg
groups and hydrolyzed in 200 μl of 6NHCl under vacuum for
12 h. The hydrolysates were dried and resuspended in 700 μl
1 mM HCl and centrifuged at 15,000 rpm for 15 min.
Supernatants were filtered and used for HPLC purposes.
Then all samples, including the ones obtained from rat tail
tendon, were prepared in duplicates.3. Results
3.1. Differential scanning calorimetry
Table 2 shows the thermometric parameters determined
by DSC for samples of myxomatous and healthy leaflets andFig. 2. An example of a DSC thermogram. From top to bottom: dog tail
tendon, diseased, and healthy (grossly uninvolved) valve leaflets. The
weights of the samples used were as follows: dog tendon 35.2 mg; healthy
valve 36.0 mg; diseased valve 36.2 mg.
Table 3
Collagen content of dog tail tendon, healthy (grossly uninvolved) dog mitral
valve leaflets, and valve leaflets from dogs affected by MMVD, determined
by quantitative analysis of hydroxyproline using an adapted form of the
Bergman and Loxley method [20]
Dried tissue (μg/mg) Wet tissue (μg/mg)
Healthy 416.15 37.48
Affected 370.06 33.15
Tail tendon 467.17 172.15
Fig. 3. The diagram shows a typical chromatogram of mature pyridinoline
cross-links. From top to bottom: diseased leaflet, healthy (grossly
uninvolved) leaflet, and rat tail.
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denaturation in affected regions of leaflets compared to that
of the adjacent grossly uninvolved areas (P≤.05). The onset
temperature of the main endothermic peak was slightly lower
in affected areas compared to the adjacent grossly unin-
volved tissue, but this was not statistically significant.
Comparing the leaflets with dog tail tendon (Fig. 2), we
found a noticeable difference in enthalpy denaturation for
both diseased and the adjacent grossly uninvolved tissues.
However, the endothermic peak in tail samples was at the
same temperature position as those of the leaflets.
3.2. Hydroxyproline assay
The assay of collagen on the basis of hydroxyproline
measurement is summarized in Table 3. Comparison of the
data for either dried or wet tissue showed that the quantity of
collagen diminished approximately 10% in the affected
tissue compared to the adjacent grossly uninvolved tissue.
The dried tissue had also been degreased, so the observed
difference in collagen content between the dried and wet
tissue suggests much higher lipid content in mitral valve
tissue compared to tail tendon.
3.3. Neutron diffraction
Table 4 shows the effect of NaB2H4 treatment on the three
different types of tissue. The results are expressed as ratios of
Bragg peak intensity, before and after reduction of the cross-Table 4
The effect of sodium borodeuteride treatment on the meridional diffraction
pattern of collagen from dog tail tendon, healthy (grossly uninvolved) dog











1 1.00 1.00 1.00 1.00
2 1.05 0.94 0.94 0.90
3 0.95 0.91 0.93 0.93
4 1.14 0.96 0.99 0.80
5 1.22 1.01 1.01 1.15
6 1.27 1.01 1.03 1.37
7 1.31 0.98 1.05 2.16
The data were calculated by dividing the diffracted intensity of treated
tissue by the corresponding intensity of untreated tissue. The data sets have
been scaled to give a first-order ratio of 1.0. Also shown are corresponding
ratios from rat tail tendon, calculated from Wess et al. [21].links. There were clear differences in the pattern of altered
intensities between tail tendon and healthy heart valve tissue.
The intensity changes are larger in tail tendon, suggesting
that all mitral leaflets, irrespective of their pathological status
(healthy or diseased), have only a small number of reducible
cross-links. However, there are also clear differences
between the healthy and diseased valves, with the pattern
of diseased valves more resembling that of dog tail tendon,
implying an increase in the amount of reducible cross-links
in the leaflets affected by MMVD.
3.4. High-performance liquid chromatography
A series of different runs were completed using various
concentrations of standard mature cross-link in order to
characterize the exact appearance of the related peaks in the
chromatogram and secondly to produce a standard graph.
Fig. 3 shows a typical chromatogram of mature cross-links.
Taking into account the pattern of the chromatogram of
amino acids, we conducted another series of HPLC runs
using standard amino acids in order to calibrate the machine
and also to see whether there would be any possible peak
interference with those of standard mature cross-links. It is
apparent from the figure that, in all runs, only one type of
mature cross-link, namely, pyridinoline, was detectable inFig. 4. The figure shows the amount of the pyridinoline cross-links in 20 μg
of collagen sample. The error bars are derived from standard deviation and
for healthy (grossly uninvolved), diseased, and rat tail are 1.53, 1.16, and
4.37 pmol, respectively.
e146 M. Hadian et al. / Cardiovascular Pathology 19 (2010) e141–e148the rat tail and valve samples irrespective of their disease
status. The analytical areas for the respective peaks were
determined, and the concentration of pyridinoline was
calculated in terms of picomoles. Statistical analysis was
carried out using Kruskal–Wallis for analysis of variance
(P≤.05). Fig. 4 shows the amount of the pyridinoline cross-
links in the respective samples. It can be seen that the amount
of mature cross-link, pyridinoline, in healthy leaflets is
significantly greater than that in diseased leaflets.
3.5. Reanalysis of X-ray data
In order to compare the new data from this study with
results already published by the authors, a reanalysis was
performed on X-ray diffraction data from a study that mapped
collagen fibrils and its quantitative and qualitative values in
affected and the adjacent grossly uninvolved areas of
(MMVD) leaflets [10]. The reanalysis was performed on the
summed meridional diffraction intensities; normalized using
readings taken from ion chambers placed before and after the
sample. This produced a value that is proportional to the
collagen fibril content per unit mass of tissue. The results of
reanalysis of X-ray data confirmed a 20% decrease in intact
collagen fibrils in the diseased areas (P≤.05). It should be
noted that this diffraction technique reports the relative
amounts of diffracting structure (i.e., collagen fibrils) and does
not take into account the presence of nonfibrillar collagen.4. Discussion
This study demonstrated a 10% reduction in total collagen
and a 20% reduction in fibrillar collagen content in the
myxomatous areas of canine valves with mild to moderate
disease. Furthermore, there is an increase in immature
reducible covalent cross-links in diseased areas, while the
amount of nonreducible mature cross-links has declined in
the same diseased leaflets. Cross-links contribute to collagen
mechanical strength, and a combination of collagen loss,
failure to form collagen fibrils, and abnormal cross-linkages
would all contribute to reduced mechanical strength. The
potential confounding factor that these changes might be a
natural age-dependent alteration in collagen expression was
overcome by comparing diseased and the adjacent grossly
uninvolved areas within the same leaflet. Considering the
close age association with MMVD, this is important as it
suggests a true disease-associated dyscollagenesis rather
than an age-related change.
Previous reports on collagen changes in MMVD in both
dogs and humans have been incomplete, mainly descriptive,
or even contradictory [4,6–9]. We have previously demon-
strated reduction in total collagen content and alteration in
collagen alignment and how these changes are located to a
narrow distal zone at the valve edge [10]. Furthermore, we
have shown that such changes can be patchy in distribution
and this understanding of the local and regional alteration incollagen deposition, collagen alignment, and collagen matura-
tion has significantly improved our understanding of disease
pathogenesis. The data presented here are only for mild to
moderately affected leaflets, and the extent of further change
in severe forms of the disease cannot be determined from the
present study. However, we have demonstrated that distinct
changes are already apparent in the early stages of this disease,
which can be presumed to contribute to abnormalities of
mechanical function of the mitral valve complex.
Measurements of the melting process by DSC give insight
into the structural alteration that occurs with myxomatous
degeneration. The thermal stability of collagen depends on
the level of hydration of collagen and the number and the
nature of covalent cross-links [27,28]. The mechanism of
denaturation is based on an irreversible process beginning
with the rupture of hydrogen bonds uncoupling the three α-
chains followed by breakage of the cross-link bonds [29,30].
In the presence of thermally stable cross-links, dehydration
may have a role in this process by reducing the free volume
available for denaturation of α-chains in the collagen fibers
[31]. Furthermore, dehydrated collagen would be confined in
a spatial arrangement within the lattice of the fiber,
decreasing the entropy and subsequently raising the thermal
stability of collagen (polymer-in-a-box theory). An alter-
native explanation is that, with fiber dehydration, water
molecules that are connected via hydrogen bonds to the triple
helix itself would be gradually stripped away. Some of these
molecules are involved in water bridge structures that
connect one α-chain to another. These hydrogen bonds
would need to be broken on denaturation. The stripping
away of water bridge molecules means fewer hydrogen
bonds need to be broken to separate and uncouple the α-
chains and reduce collagen to random coils. At an
ultrastructural level, this collagen disorganization can be
seen in dog mitral valves on transmission electron micro-
scopy [9].
Although the enthalpy of denaturation was decreased by
20% in diseased valve tissue, this effect cannot simply be
due to collagen depletion as the hydroxyproline assay only
identified a 10% decrease in collagen. Together these
findings demonstrate qualitative and quantitative changes
in valve collagen. There was no significant difference in the
onset temperature of denaturation comparing diseased and
the adjacent grossly uninvolved tissue samples. It is already
known that a change in pH or concentration of ions around
the collagen molecules only influences the temperature but
not the enthalpy of denaturation [32], and it is likely that
changes in amino acid composition have a similar effect. The
most likely explanation for this diminished enthalpy is that
not all of the collagen molecules are in the form of intact and
regularly structured triple helices and/or fibrils. This was
confirmed by a reanalysis of data from our previous X-ray
diffraction study. Only the regularly ordered and intact fibrils
could contribute to the diffraction pattern, and by comparing
affected and grossly uninvolved leaflets there is a clear 20%
decrease in intact collagen fibrils. This nonfibrillous collagen
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fibrils, uncoupling of the α-chains as a result of enzymatic
depolymerization and subsequent denaturation, and, finally,
an alteration in the nature and number of the cross-links
responsible for strengthening the collagen helices. Overall,
these factors would not affect the onset temperature of
denaturation, but the enthalpy would undergo some changes.
This would be consistent with the findings of a previous
study carried out on the superficial digital flexor tendon
degeneration in horses which showed that the enthalpy of
denaturation of degenerated tendon was less than that of
normal tendon, whereas the temperature characteristics were
the same [32]. Interestingly, both these diseases appear in
advanced age and both have been suggested to be associated
with a repeated injury mechanism.
The neutron diffraction data from dog tail showed the
systematic changes that are comparable to those reported by
Wess et al. [21,22], indicating the presence of a high number
of reducible cross-links in the tendon tail. The mitral valve
results showed a marked difference in the number of
reducible cross-links compared to tail tendon irrespective
of pathological status. However, according to the same set of
neutron data, there was a higher level of reducible cross-links
in the diseased leaflet. Complementing this data, HPLC
showed that the amounts of nonreducible mature cross-links
were higher in healthy leaflets. Cross-links are formed
through the intermolecular reactions of aldehyde residues
catalyzed by lysyl oxidase. Initially, there are two pathways
based on the precursor, namely, lysine aldehyde and
hydroxylysine aldehyde. The latter is the predominant
form in most connective tissues. Both of these pathways
lead to the production of cross-links which are primary
borohydride reducible giving the opportunity to be investi-
gated by neutron diffraction. During the course of maturation
of the fibrils, these reducible cross-links tend to be replaced
by mature nonreducible cross-links [33]. Pyridinoline and
deoxypyridinoline have been identified so far as two
important mature nonreducible cross-links, with deoxypyr-
idinoline almost exclusively associated with bone tissue. The
cross-links are a major contributor to the expected strength
and mechanical properties of collagen.
The observed changes in the amount of cross-links can be
interpreted in a variety of ways. Studies of other systems
have shown that, with the advancing of age and as MMVD is
an age-related disease, the activity of lysyl oxidase
decreases. This means that, in general, older tissues will
tend to have fewer cross-links [33]. Increased deposition of
proteoglycans, which is recognized to occur with MMVD,
might interfere with the formation of cross-links [34]. Lastly,
accumulation of advanced glycation end products (AGEs),
which are nonenzymatic cross-links derived from prolonged
exposure to monosaccharides, has also been reported to have
detrimental effects on the mechanical properties of con-
nective tissues and might also interfere with the formation of
enzymatic cross-links. There is increasing interest in the role
of AGEs in the process of aging [35,36]. However, in thecurrent study, the alteration in cross-links could be explained
in terms of dyscollagenesis associated with myofibroblasts
activation [10,11]. The products of activated myofibroblasts
would be immature collagen molecules, and as turnover
increases there may not be enough time for the transforma-
tion of immature reducible cross-links to the mature ones.
The reduction in tensile strength of the leaflets could further
contribute to mitral valve prolapse and leaflet extensibility,
both of which are features of MMVD in dogs and MVP in
humans [37,38]. This in itself could contribute to ongoing
and progressive pathological changes to the leaflets.
In conclusion, this study has demonstrated changes in
fibrillar collagen, total collagen content, and collagen cross-
links in mild to moderate MMVD in the dog and provides
evidence that the pathology of this disease involves a process
of dyscollagenesis. These findings have implications for
understanding the natural progression of this disease both in
dogs and in humans.
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